title: Eradication of parvovirus B19 infection after renal transplantation requires reduction of immunosuppression and high-dose immunoglobulin therapy.
authors.affiliation: Department of Nephrology, Charité, Humboldt-University Berlin, Germany. lutz.liefeldt@charite.de
authors.forename: Lutz
authors.initials: L
authors.lastname: Liefeldt
authors.forename: Martin
authors.initials: M
authors.lastname: Buhl
authors.forename: Britta
authors.initials: B
authors.lastname: Schweickert
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Engelmann
authors.forename: Orhan
authors.initials: O
authors.lastname: Sezer
authors.forename: Peter
authors.initials: P
authors.lastname: Laschinski
authors.forename: Lothar
authors.initials: L
authors.lastname: Preuschof
authors.forename: Hans-H
authors.initials: HH
authors.lastname: Neumayer
mesh_terms: D000328:Adult; D000740:Anemia / Q000821:virology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007136:Immunoglobulins / Q000008:administration & dosage*; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D016030:Kidney Transplantation; D008297:Male; D010322:Parvoviridae Infections / Q000150:complications / Q000209:etiology*; D016732:Parvovirus B19, Human
chemical_list: D007136:Immunoglobulins